Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients

J Dermatol. 2015 Jan;42(1):98-9. doi: 10.1111/1346-8138.12740. Epub 2014 Dec 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adjuvants, Immunologic / pharmacology
  • Adjuvants, Immunologic / therapeutic use*
  • Alopecia Areata / immunology
  • Alopecia Areata / therapy*
  • Cyclobutanes / pharmacology
  • Cyclobutanes / therapeutic use*
  • Humans
  • Immunotherapy
  • Prospective Studies
  • Th1 Cells
  • Th17 Cells

Substances

  • Adjuvants, Immunologic
  • Cyclobutanes
  • squaric acid dibutyl ester